Association between BDNF G196A (Val66Met) polymorphism and cognitive impairment in patients with Parkinson's disease: a meta-analysis.

In conclusion, BDNF G196A (Val66Met) is confirmed to be a risk factor for cognitive impairment in PD.
PMID: 31365694 [PubMed - in process]

Source: Braz J Med Biol Res - August 2, 2019 Category: Research Authors: Wang Q, Liu J, Guo Y, Dong G, Zou W, Chen Z Tags: Braz J Med Biol Res Source Type: research